CD51/CD61+ Endothelial Microparticles Decrease in Diabetes Patients with Hypertension

Authors

  • Shuai-Shuai Hu Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • Hong-gang Zhang Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • Qiuju Zhang Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
  • Ruijuan Xiu Institute of Microcirculation, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China

Keywords:

Diabetes mellitus, Hypertension, Endothelial microparticles, Endothelial dysfunction

Abstract

Backgrounds: Type 2 Diabetes Mellitus (T2DM) and hypertension are commonly co-occurred and both diseases are related to endothelial dysfunction. Endothelial microparticles (EMPs) are shed from endothelial cells and can be found in condition of endothelial dysfunction. This study aimed to evaluate the circulating endothelial MPs (CD51/CD61+) levels in T2DM patients with or without hypertension and the correlation between endothelial MPs and clinical parameters. Methods and Results: 20 healthy control, 16 T2DM patients without hypertension and 11 T2DM patients with hypertension were recruited. CD51/CD61+ EMPs from all subjects were analyzed by flow cytometry. We found that, in the group of T2DM patients with hypertension, the absolute median number of CD51/CD61+EMPs was significantly decreased, compared with that in the healthy control and T2DM without hypertension groups. Furthermore, we conducted receiver operating characteristics (ROC) analysis to examine the accuracy of CD51/CD61+EMPs in the discrimination  between T2DM patients with hypertension and healthy control, showing the accuracy was 76.4%. In addition, we also found that the accuracy of CD51/CD61+EMPs was 83.5% in the discrimination between T2DM patients with hypertension or without hypertension Conclusion: These findings identify CD51/CD61+EMPs as a potential biomarker to monitor endothelial dysfunction in T2DM patients with hypertension.

References

. E. Ferrannini and W. C. Cushman. “Diabetes and hypertension: The bad companions.” Lancet, vol. 380, pp. 601-10, Aug. 2012.

. J. R. Petrie, T. J. Guzik, and R. M. Touyz. “Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms.” Canadian Journal of Cardiology, vol. 34, pp. 575-584, May. 2018.

. H. A. R. Hadi, C. S. Carr, and J. Al Suwaidi. “Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.” Vascular health and risk management, vol. 1, pp. 183-98, 2005.

. W. T. Wong, X. Y. Tian, and Y. Huang. “Endothelial dysfunction in diabetes and hypertension: Cross talk in RAS, BMP4, and ROS-dependent COX-2-derived prostanoids.” Journal of Cardiovascular Pharmacology, vol. 61, pp. 204-14, Mar. 2013.

. F. Deng, S. Wang, and L. Zhang.“Endothelial Microparticles Act as Novel Diagnostic and Therapeutic Biomarkers of Diabetes and Its Complications: A Literature Review.” BioMed Research International, vol. 2016, Oct. 2016.

. T. Helbing, C.Olivier, C.Bode, M.Moser and P.Diehl. “Role of microparticles in endothelial dysfunction and arterial hypertension.” World J. Cardiol, vol. 6, pp. 1135-9, Nov. 2014.

. S. S. Hu, H. G. Zhang, Q. J. Zhang, and R. J. Xiu. “Increased Circulating Apoptotic CD31+/CD42b- and Activated CD62E+ Endothelial Micro Particles in Coronary Artery Disease.” J. Hypertens, vol. 3, pp. Jan. 2013.

. A. F. Tramontano, R. Lyubarova, J. Tsiakos, T. Palaia, J. R. Deleon, and L. Ragolia.“Circulating endothelial microparticles in diabetes mellitus.” Mediators Inflamm, vol. 2010, Jun. 2010.

. M. Dec-Gilowska, M. Trojnar, B. Makaruk, M. Czop, S. Przybylska-Kuc, B. Mosiewicz-Madejska, et al. “Circulating endothelial microparticles and aortic stiffness in patients with type 2 diabetes mellitus.” Med, vol. 55, Sep. 2019.

. S. S. Hu, H. G. Zhang, Q. J. Zhang, and R. J. Xiu. “CD51+ endothelial microparticles as a biomarker of endothelial dysfunction in obese patients with hypertension.” Endocrine, vol. 49, pp. 283-5, May. 2015.

Downloads

Published

2020-04-30

How to Cite

Hu, S.-S. ., Zhang, H.- gang ., Zhang, Q. ., & Xiu, R. . (2020). CD51/CD61+ Endothelial Microparticles Decrease in Diabetes Patients with Hypertension. International Journal of Sciences: Basic and Applied Research (IJSBAR), 51(2), 88–94. Retrieved from https://www.gssrr.org/index.php/JournalOfBasicAndApplied/article/view/11024

Issue

Vol. 51 No. 2 (2020)

Section

Articles

License

Authors who submit papers with this journal agree to the following terms.